Ariel discloses 29.4% stake in Core Laboratories (CLB)
Ariel Investments, LLC filed Amendment No. 8 to Schedule 13G reporting a significant passive stake in Core Laboratories Inc. (CLB).
Rhea-AI Filing Summary
Ariel Investments, LLC filed Amendment No. 8 to Schedule 13G reporting a significant passive stake in Core Laboratories Inc. (CLB). Ariel reports beneficial ownership of 13,773,568 shares, representing 29.4% of the common stock as of the event date.
Ariel has sole voting power over 13,013,344 shares and sole dispositive power over 13,773,568 shares, with no shared voting or dispositive power. The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. Within Ariel’s advised accounts, Ariel Fund holds 6,518,877 shares, representing an economic interest in more than 5% of the class.
Positive
- None.
Negative
- None.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in CLB did Ariel Investments report on Schedule 13G/A?
Which Ariel-advised fund holds more than 5% of CLB?
What is the filing type and amendment number for Ariel’s disclosure?
What does Ariel certify about its intent regarding CLB control?
What is the event date tied to this ownership disclosure?
AI-generated analysis. How Rhea-AI works. Not financial advice.